Pityriasis Alba in Emergency Medicine Workup
- Author: Rashid M Rashid, MD, PhD; Chief Editor: Pamela L Dyne, MD more...
Laboratory Studies
- A workup may be undertaken to exclude other causes of hypopigmentation; however, most of this would be accomplished through a dermatology referral.
- As an emergency physician, a Wood's light examination may help in evaluating the patient whose rash is due to vitiligo. Vitiligo will glow more brightly and will have edges with sharper demarcation.
- Potassium hydroxide stain of a skin scraping will be positive if the patient has tinea versicolor, which has an alternate name of pityriasis versicolor. This would likely be performed by a dermatologist.
- A biopsy would be required for atypical lesions as noted in the differential. This would likely be performed by a dermatologist.
Other Tests
- Hypopigmentation may occur in other disorders, such as those caused by fungi (eg, tinea versicolor), previous inflammatory conditions (eg, postinflammatory hypopigmentation), idiopathic disorders (eg, vitiligo), or malignancy (mycosis fungoides), or it may occur secondary to medications such as retinoic acid, benzoyl peroxide, and topical steroids. Clinicians should rule out these other disorders when evaluating a patient who may have pityriasis alba.
Procedures
- A biopsy of the lesions usually is not necessary and is not indicated in the emergency department. Pathologic findings are nonspecific; however, findings may include a basal layer with irregular pigmentation, follicular plugging, edema between epithelial cells (ie, spongiosis), or atopy of the sebaceous glands. However, this is required in atypical cases and should be performed in the office of a specialist in skin disease. It is of particular concern, considering the common location of the cheek and the potential approximation of this area to the facial artery.
- Details of biopsy results are noted in Pathophysiology.
Di Lernia V, Ricci C. On atopic and idiopatic extensive pityriasis alba. Pediatr Dermatol. Sep-Oct 2007;24(5):578-9. [Medline].
Vinod S, Singh G, Dash K, Grover S. Clinico epidemiological study of pityriasis alba. Indian J Dermatol Venereol Leprol. Nov-Dec 2002;68(6):338-40. [Medline].
In SI, Yi SW, Kang HY, Lee ES, Sohn S, Kim YC. Clinical and histopathological characteristics of pityriasis alba. Clin Exp Dermatol. Jul 2009;34(5):591-7. [Medline].
Brenninkmeijer EE, Spuls PI, Legierse CM, Lindeboom R, Smitt JH, Bos JD. Clinical differences between atopic and atopiform dermatitis. J Am Acad Dermatol. Mar 2008;58(3):407-14. [Medline].
Fujita WH, McCormick CL, Parneix-Spake A. An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba. Int J Dermatol. Jul 2007;46(7):700-5. [Medline].
Al-Mutairi N, Hadad AA. Efficacy of 308-nm Xenon Chloride Excimer Laser in Pityriasis Alba. Dermatol Surg. Nov 28 2011;[Medline].
Lin RL, Janniger CK. Pityriasis alba. Cutis. Jul 2005;76(1):21-4. [Medline].
Ortonne JP, Passeron T. Melanin pigmentary disorders: treatment update. Dermatol Clin. Apr 2005;23(2):209-26. [Medline].
Rakel RE, Bope ET. Conn's Current Therapy 2005. 57th ed. St Louis: WB Saunders; 2005:999.
Sams WM. Principles and Practice of Dermatology. New York: Churchill; 1990:369.
Vargas-Ocampo F. Pityriasis alba: a histologic study. Int J Dermatol. Dec 1993;32(12):870-3. [Medline].

